Impact Factor 4.416

Frontiers journals are at the top of citation and impact metrics

Correction ARTICLE

Front. Oncol., 21 September 2018 | https://doi.org/10.3389/fonc.2018.00307

Corrigendum: Circular RNAs in Cancer – Lessons Learned From microRNAs

  • 1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
  • 2Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • 3Department of Surgery, Fundeni Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • 4Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

A corrigendum on
Circular RNAs in Cancer – Lessons Learned From microRNAs

by Dragomir, M., and Calin, G. A. (2018). Front. Oncol. 8:179. doi: 10.3389/fonc.2018.00179

In the original article, the details for reference (70) were incorrect. The In Press version of the article was cited instead of the final published article. The full reference appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

70. L'Abbate A, Tolomeo D, Cifola I, Severgnini M, Turchiano A, Augello B, et al. MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences. Leukemia (2018) doi: 10.1038/s41375-018-0033-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: circular RNA, microRNA, non-coding RNAs, cancer, biomarker

Citation: Dragomir M and Calin GA (2018) Corrigendum: Circular RNAs in Cancer – Lessons Learned From microRNAs. Front. Oncol. 8:307. doi: 10.3389/fonc.2018.00307

Received: 19 July 2018; Accepted: 20 July 2018;
Published: 21 September 2018.

Approved by: Frontiers in Oncology Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2018 Dragomir and Calin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: George A. Calin, gcalin@mdanderson.org